Big Pharma Under Fire: Disturbing New Evidence Vaccines Were Delayed to Get Trump Out of Office

Meanwhile, HHS is signaling it's about to make a huge announcement about the Covid vaccines.

The political gamesmanship around COVID-19 vaccines is back in the spotlight. A new House Judiciary probe, spearheaded by Chairman Jim Jordan (R-Ohio), is digging into whether Pfizer intentionally delayed announcing successful vaccine trial results until after the 2020 election — a move that could have denied then-President Trump a major public health and political win.

According to internal GSK communications cited by the committee, Phil Dormitzer — a former Pfizer vaccine R&D leader who later joined GSK — allegedly told colleagues Pfizer's "three most senior" R&D officials deliberately slowed testing so the results wouldn't be finalized before the election.

Dormitzer has denied the allegations, but GOP lawmakers are demanding documents and communications from Pfizer executives dating back to March 2020.

This builds on a Wall Street Journal report that federal prosecutors are reviewing Dormitzer’s comments and possible suppression of trial data. Pfizer announced its 90% efficacy figure just two days after the election — without full safety data and amid accusations of hiding deaths during trials.

Trump claimed at the time that Pfizer “didn’t have the courage” to release results before the vote. Now, Jordan wants to know if it was more than cowardice — if it was calculated.

While the political debate rages on in Washington D.C., a growing body of peer-reviewed research is renewing scrutiny of vaccine safety, especially for women and children.

A March study in Vaccines (MDPI) examined how mRNA and traditional COVID vaccines affect ovarian reserves in rats. Both types, especially the mRNA jabs, significantly reduced the number of follicles—key indicators of fertility. The researchers called for further human studies, while critics like epidemiologist Nicolas Hulscher and the Children’s Health Defense warned of long-term reproductive risks.

“This could be a demographic time bomb,” said analyst Edward Dowd, referencing prior data on miscarriages and birth defects from Pfizer trials that remained hidden for 16 months.

Another peer-reviewed study in Human Vaccines & Immunotherapeutics found that spike proteins from mRNA vaccines can persist in the body for up to 245 days — far longer than expected. A Yale-led study still under peer review suggests spike persistence could stretch to nearly two years.

“We knew back in 2021 that some patients were dealing with long-term vaccine side effects,” said Dr. Ram Yogendra of Lawrence General Hospital. “But we were silenced, defamed, and threatened.” He says the Yale data vindicates his team’s early findings.

Further complicating the safety narrative: A study in the Journal of Clinical Endocrinology and Metabolism found a significant rise in both underactive and overactive thyroid conditions among mRNA vaccine recipients 6 to 12 months post-shot. Taiwanese researchers behind the study used a large matched cohort and a full year of follow-up.

Dr. Mary Talley Bowden, a vocal vaccine critic whose legal actions prompted the FDA to stop mocking ivermectin online, noted on X: “25,000 children a day are getting the latest mRNA shot. Four years in, I still see patients severely harmed by these vaccines.”

She said she'll give HHS Secretary Robert F. Kennedy Jr. credit when “these products are pulled off the market.”

The Department of Health and Human Services is reportedly preparing to halt routine COVID vaccine recommendations for pregnant women, teens, and children — more than 100 days into Kennedy's term. If implemented, this would mark a major policy reversal — and a strong signal that critics may have had a point all along.